Ultragenyx Pharmaceutical's total assets for Q3 2025 were $1.19B, a decrease of -8.87% from the previous quarter. DE:UP0 total liabilities were $1.17B for the fiscal quarter, a 2.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.